Health minister calls on local authority leaders to tackle TB and Hep C

Local authority leaders, in areas with high rates of TB or Hepatitis C infection, were called together by the Minister for Public Health, Jane Ellison, to examine actions and interventions to address the two diseases. The minister outlined the similarities between the two diseases; including their links to health inequalities and challenges relating to ensuring […]

Continue Reading

Uncertain future for European TB funding

A new report by the TB Europe Coalition, “After Aid: What is next for TB and HIV in Europe”, examines the potential consequences for TB in Europe as key international donors withdraw support for European TB programmes, to refocus efforts on lower-income countries with a higher disease burden. “I am very worried. I had to […]

Continue Reading

Trillion Euro bill for multi drug-resistant TB

Startling new data has predicted that by 2050, 75 million people could lose their lives to multi drug-resistant TB (MDR-TB) at a cost of €15.6 trillion to the global economy—the equivalent of the entire annual economic output of the European Union. These projections were originally produced for the independent Review on Anti-Microbial Resistance (AMR) and […]

Continue Reading

USAID and Janssen provide free drugs for MDR-TB

The United States Agency for International Development (USAID) and Janssen Therapeutics, have agreed to provide a newly developed tuberculosis drug for free to patients suffering from strains of TB that are resistant to two or more antibiotics. Janssen will donate $30 million worth (30,000 treatment courses) of the drug SIRTURO® (bedaquiline) over a 4 year […]

Continue Reading

Drug resistance to cost $100tn by 2050, study finds

Over the next 15 years, drug resistant infections – including tuberculosis – will cause 10m deaths a year worldwide and will cost at least $100 trillion – unless global action is taken. These are the findings of the Review on Antimicrobial Resistance, which was set up by David Cameron, the UK’s prime minister. The report, […]

Continue Reading

PET and CT scanning could show if TB treatment is effective

The medical imaging techniques, positron emission tomography (PET) and computed tomography (CT), could help predict the effectiveness of antibiotic drug treatment for TB patients. Researchers at the US National Institutes of Health have shown how PET/CT imaging can demonstrate changes to tissue and organ functioning following antibiotic treatment, in both TB-infected monkeys and humans. Currently, cultures are used to […]

Continue Reading

TB Alert partners receive global funding for TB training in prisons

TB Alert’s Zambian partner, Chichetekelo Outreach Partners (COP), recently received a grant of $20,000 from the Stop TB Partnership’s Challenge Facility for Civil Society. COP have used the funding to provide TB training for prison officers, from prisons across the Kabwe district, providing the latest knowledge on TB, the links between TB and HIV, and […]

Continue Reading

Celebrating innovation in TB nursing

TB Alert is pleased to announce the launch of the first award of its kind to recognise the crucial role that TB Nurses provide in the UK towards TB care and control: The Sir John Crofton Prize for TB Nursing, sponsored by Oxford Immunotec. TB nurses are at the forefront of patient care in the […]

Continue Reading

WHO launches guidelines on management of latent TB

The World Health Organization (WHO) has issued guidelines on testing, treating and managing latent TB infection (LTBI) in individuals with high risk of developing the disease. The new guidelines on the management of LTBI provide public health approach guidance on evidence-based practices for testing, treating and managing LTBI in infected individuals with the highest likelihood […]

Continue Reading
MENU